Oric Pharmaceuticals Files 8-K

Ticker: ORIC · Form: 8-K · Filed: Dec 8, 2025 · CIK: 1796280

Oric Pharmaceuticals, Inc. 8-K Filing Summary
FieldDetail
CompanyOric Pharmaceuticals, Inc. (ORIC)
Form Type8-K
Filed DateDec 8, 2025
Risk Levellow
Pages1
Reading Time2 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 8-k, regulatory-update

TL;DR

ORIC filed an 8-K on 12/8/25 for other events and exhibits.

AI Summary

Oric Pharmaceuticals, Inc. filed an 8-K on December 8, 2025, reporting other events and financial statements/exhibits. The filing date for the report is December 6, 2025. The company is incorporated in Delaware and its principal executive offices are located at 240 E. Grand Ave, 2nd Floor, South San Francisco, CA 94080.

Why It Matters

This 8-K filing indicates that Oric Pharmaceuticals is making a regulatory submission to the SEC, which could contain important updates or disclosures about the company's operations or financial status.

Risk Assessment

Risk Level: low — This filing is a routine SEC disclosure and does not appear to contain any immediately alarming information.

Key Numbers

  • 20251208 — Filing Date (Date the 8-K was filed with the SEC.)
  • 20251206 — Report Date (Earliest event date reported in the filing.)

Key Players & Entities

  • Oric Pharmaceuticals, Inc. (company) — Registrant
  • Delaware (jurisdiction) — State of incorporation
  • 240 E. Grand Ave, 2nd Floor, South San Francisco, CA 94080 (address) — Principal executive offices
  • 001-39269 (company_id) — Commission File Number
  • 47-1787157 (company_id) — IRS Employer Identification No.

FAQ

What specific 'Other Events' are detailed in this 8-K filing?

The provided text does not specify the 'Other Events' beyond listing it as an item information category. A review of the full filing document would be necessary to determine the specifics.

What is the significance of the 'Financial Statements and Exhibits' being filed?

This indicates that the company is providing updated financial information or submitting supporting documents as required by the SEC, which could include financial reports or other relevant materials.

What is Oric Pharmaceuticals, Inc.'s Standard Industrial Classification (SIC) code?

Oric Pharmaceuticals, Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.

What is the company's telephone number?

The company's telephone number is (650) 388-5600.

Is this filing related to a specific event like an acquisition or earnings release?

The filing is categorized under 'Other Events' and 'Financial Statements and Exhibits,' and does not explicitly mention an acquisition or earnings release in the provided text. Further details would be in the full document.

Filing Stats: 437 words · 2 min read · ~1 pages · Grade level 10.3 · Accepted 2025-12-08 06:02:30

Key Financial Figures

  • $0.0001 — ich registered Common stock, par value $0.0001 per share ORIC The Nasdaq Global Se

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Presentation 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ORIC PHARMACEUTICALS, INC. Date: December 8, 2025 By: /s/ Christian V. Kuhlen Christian V. Kuhlen, M.D., J.D. General Counsel

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.